Logo image of FRE.DE

FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis

FRA:FRE - Deutsche Boerse Ag - DE0005785604 - Common Stock - Currency: EUR

44  -0.24 (-0.54%)

Fundamental Rating

4

Taking everything into account, FRE scores 4 out of 10 in our fundamental rating. FRE was compared to 30 industry peers in the Health Care Providers & Services industry. The financial health of FRE is average, but there are quite some concerns on its profitability. FRE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year FRE was profitable.
FRE had a positive operating cash flow in the past year.
Of the past 5 years FRE 4 years were profitable.
In the past 5 years FRE always reported a positive cash flow from operatings.
FRE.DE Yearly Net Income VS EBIT VS OCF VS FCFFRE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

FRE has a Return On Assets of 0.98%. This is in the lower half of the industry: FRE underperforms 66.67% of its industry peers.
The Return On Equity of FRE (2.17%) is worse than 66.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.69%, FRE is doing worse than 66.67% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for FRE is below the industry average of 6.19%.
The last Return On Invested Capital (2.69%) for FRE is above the 3 year average (1.83%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.98%
ROE 2.17%
ROIC 2.69%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
FRE.DE Yearly ROA, ROE, ROICFRE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

With a Profit Margin value of 1.91%, FRE perfoms like the industry average, outperforming 43.33% of the companies in the same industry.
In the last couple of years the Profit Margin of FRE has declined.
With a decent Operating Margin value of 8.68%, FRE is doing good in the industry, outperforming 73.33% of the companies in the same industry.
In the last couple of years the Operating Margin of FRE has declined.
FRE has a Gross Margin (24.48%) which is comparable to the rest of the industry.
FRE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.68%
PM (TTM) 1.91%
GM 24.48%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
FRE.DE Yearly Profit, Operating, Gross MarginsFRE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

FRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, FRE has about the same amount of shares outstanding.
The number of shares outstanding for FRE has been increased compared to 5 years ago.
Compared to 1 year ago, FRE has an improved debt to assets ratio.
FRE.DE Yearly Shares OutstandingFRE.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
FRE.DE Yearly Total Debt VS Total AssetsFRE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

FRE has an Altman-Z score of 1.99. This is not the best score and indicates that FRE is in the grey zone with still only limited risk for bankruptcy at the moment.
FRE has a Altman-Z score of 1.99. This is comparable to the rest of the industry: FRE outperforms 60.00% of its industry peers.
The Debt to FCF ratio of FRE is 8.76, which is on the high side as it means it would take FRE, 8.76 years of fcf income to pay off all of its debts.
FRE's Debt to FCF ratio of 8.76 is in line compared to the rest of the industry. FRE outperforms 53.33% of its industry peers.
FRE has a Debt/Equity ratio of 0.62. This is a neutral value indicating FRE is somewhat dependend on debt financing.
FRE has a Debt to Equity ratio of 0.62. This is in the better half of the industry: FRE outperforms 76.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 8.76
Altman-Z 1.99
ROIC/WACC0.53
WACC5.03%
FRE.DE Yearly LT Debt VS Equity VS FCFFRE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 1.43 indicates that FRE should not have too much problems paying its short term obligations.
FRE has a Current ratio of 1.43. This is in the better half of the industry: FRE outperforms 66.67% of its industry peers.
A Quick Ratio of 1.11 indicates that FRE should not have too much problems paying its short term obligations.
FRE has a Quick ratio of 1.11. This is in the better half of the industry: FRE outperforms 70.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.11
FRE.DE Yearly Current Assets VS Current LiabilitesFRE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

FRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 785.11%, which is quite impressive.
Measured over the past years, FRE shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.29% on average per year.
The Revenue for FRE has decreased by -20.12% in the past year. This is quite bad
The Revenue has been decreasing by -9.22% on average over the past years.
EPS 1Y (TTM)785.11%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%31.34%
Revenue 1Y (TTM)-20.12%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%-0.93%

3.2 Future

FRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.10% yearly.
The Revenue is expected to grow by 4.98% on average over the next years.
EPS Next Y10.09%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
EPS Next 5Y10.1%
Revenue Next Year4.95%
Revenue Next 2Y4.99%
Revenue Next 3Y5.02%
Revenue Next 5Y4.98%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FRE.DE Yearly Revenue VS EstimatesFRE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10B 20B 30B 40B
FRE.DE Yearly EPS VS EstimatesFRE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.66, the valuation of FRE can be described as correct.
Based on the Price/Earnings ratio, FRE is valued a bit cheaper than the industry average as 76.67% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of FRE to the average of the S&P500 Index (26.31), we can say FRE is valued slightly cheaper.
FRE is valuated reasonably with a Price/Forward Earnings ratio of 11.87.
Based on the Price/Forward Earnings ratio, FRE is valued a bit cheaper than 66.67% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of FRE to the average of the S&P500 Index (22.13), we can say FRE is valued slightly cheaper.
Industry RankSector Rank
PE 13.66
Fwd PE 11.87
FRE.DE Price Earnings VS Forward Price EarningsFRE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

FRE's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. FRE is more expensive than 60.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, FRE is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 15.95
EV/EBITDA 10.45
FRE.DE Per share dataFRE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

FRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.35
PEG (5Y)N/A
EPS Next 2Y10.97%
EPS Next 3Y9.91%

4

5. Dividend

5.1 Amount

FRE has a Yearly Dividend Yield of 2.26%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.62, FRE pays a bit more dividend than its industry peers.
FRE's Dividend Yield is comparable with the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 2.26%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
FRE.DE Yearly Dividends per shareFRE.DE Yearly Dividends per shareYearly Dividends per share 2015 2016 2019 2020 2021 2022 2023 2025 0.5 1 1.5

5.3 Sustainability

22.75% of the earnings are spent on dividend by FRE. This is a low number and sustainable payout ratio.
DP22.75%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
FRE.DE Yearly Income VS Free CF VS DividendFRE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B
FRE.DE Dividend Payout.FRE.DE Dividend Payout, showing the Payout Ratio.FRE.DE Dividend Payout.PayoutRetained Earnings

FRESENIUS SE & CO KGAA

FRA:FRE (6/13/2025, 5:36:15 PM)

44

-0.24 (-0.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners42.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap24.78B
Analysts83.48
Price Target48.9 (11.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.26%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP22.75%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.13%
Min EPS beat(2)12.64%
Max EPS beat(2)17.61%
EPS beat(4)3
Avg EPS beat(4)8.93%
Min EPS beat(4)-3.48%
Max EPS beat(4)17.61%
EPS beat(8)4
Avg EPS beat(8)-53.43%
EPS beat(12)5
Avg EPS beat(12)-43.42%
EPS beat(16)8
Avg EPS beat(16)-32.16%
Revenue beat(2)2
Avg Revenue beat(2)2.62%
Min Revenue beat(2)2.4%
Max Revenue beat(2)2.84%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)2.84%
Revenue beat(8)3
Avg Revenue beat(8)-0.09%
Revenue beat(12)4
Avg Revenue beat(12)-0.24%
Revenue beat(16)6
Avg Revenue beat(16)-0.01%
PT rev (1m)5.77%
PT rev (3m)13.42%
EPS NQ rev (1m)-6.94%
EPS NQ rev (3m)-10.38%
EPS NY rev (1m)0%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)-1.03%
Revenue NQ rev (3m)-4.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.43%
Valuation
Industry RankSector Rank
PE 13.66
Fwd PE 11.87
P/S 1.12
P/FCF 15.95
P/OCF 10.08
P/B 1.28
P/tB 11.48
EV/EBITDA 10.45
EPS(TTM)3.22
EY7.32%
EPS(NY)3.71
Fwd EY8.42%
FCF(TTM)2.76
FCFY6.27%
OCF(TTM)4.37
OCFY9.92%
SpS39.25
BVpS34.46
TBVpS3.83
PEG (NY)1.35
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.98%
ROE 2.17%
ROCE 5.5%
ROIC 2.69%
ROICexc 3.02%
ROICexgc 6.65%
OM 8.68%
PM (TTM) 1.91%
GM 24.48%
FCFM 7.03%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
ROICexc(3y)1.84%
ROICexc(5y)2.65%
ROICexgc(3y)3.69%
ROICexgc(5y)5.83%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexcg growth 3Y-17.75%
ROICexcg growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score7
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 8.76
Debt/EBITDA 3.91
Cap/Depr 77.02%
Cap/Sales 4.09%
Interest Coverage 4.28
Cash Conversion 79.5%
Profit Quality 368.25%
Current Ratio 1.43
Quick Ratio 1.11
Altman-Z 1.99
F-Score7
WACC5.03%
ROIC/WACC0.53
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)785.11%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%31.34%
EPS Next Y10.09%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
EPS Next 5Y10.1%
Revenue 1Y (TTM)-20.12%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%-0.93%
Revenue Next Year4.95%
Revenue Next 2Y4.99%
Revenue Next 3Y5.02%
Revenue Next 5Y4.98%
EBIT growth 1Y9.47%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year65.74%
EBIT Next 3Y23.83%
EBIT Next 5Y16.02%
FCF growth 1Y-34.12%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-42.44%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%